On 2025-05-13, Annovis Bio, Inc. (ANVS) announced earnings per share of $-0.32 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.47.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.36 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.47 | $-0.32 |
| 2025-03-21 | 2024-12-31 | $-0.38 | $-0.43 |
| 2024-11-08 | 2024-09-30 | $-0.64 | $-0.97 |
| 2024-08-14 | 2024-06-30 | $-0.70 | $-0.44 |
| 2024-05-13 | 2024-03-31 | $-0.87 | $-0.72 |
| 2024-03-29 | 2023-12-31 | -- | $-1.09 |
| 2023-11-08 | 2023-09-30 | $-1.10 | $-1.63 |
| 2023-08-15 | 2023-06-30 | $-1.14 | $-1.07 |
| 2023-05-11 | 2023-03-31 | $-0.85 | $-1.19 |
| 2023-04-03 | 2022-12-31 | -- | $-0.38 |
| 2022-11-08 | 2022-09-30 | $-1.17 | $-0.93 |
| 2022-08-08 | 2022-06-30 | -- | $-1.07 |
| 2022-05-04 | 2022-03-31 | -- | $-0.72 |
| 2022-03-02 | 2021-12-31 | -- | $-0.75 |
| 2021-11-03 | 2021-09-30 | -- | $-0.35 |
| 2021-07-28 | 2021-06-30 | -- | $-0.34 |
| 2021-05-06 | 2021-03-31 | -- | $-0.46 |
| 2021-03-03 | 2020-12-31 | -- | $-0.26 |
| 2020-11-04 | 2020-09-30 | -- | $-0.15 |
| 2020-07-29 | 2020-06-30 | -- | $-0.34 |
| 2020-05-05 | 2020-03-31 | -- | $-0.10 |